Product References
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Cell reports. Medicine
Bagheri M,Mohamed GA,Mohamed Saleem MA,Ognjenovic NB,Lu H,Kolling FW,Wilkins OM,Das S,LaCroix IS,Nagaraj SH,Muller KE,Gerber SA,Miller TW,Pattabiraman DR
Published figure using ZEB1 polyclonal antibody (Product # PA5-82982) in Immunoprecipitation
Tue Apr 16 00:00:00 UTC 2024
An atlas of late prenatal human neurodevelopment resolved by single-nucleus transcriptomics.
Nature communications
Ramos SI,Mussa ZM,Falk EN,Pai B,Giotti B,Allette K,Cai P,Dekio F,Sebra R,Beaumont KG,Tsankov AM,Tsankova NM
Published figure using ZEB1 polyclonal antibody (Product # PA5-82982) in Immunocytochemistry
Mon Dec 12 00:00:00 UTC 2022
An atlas of late prenatal human neurodevelopment resolved by single-nucleus transcriptomics.
Nature communications
Ramos SI,Mussa ZM,Falk EN,Pai B,Giotti B,Allette K,Cai P,Dekio F,Sebra R,Beaumont KG,Tsankov AM,Tsankova NM
Published figure using ZEB1 polyclonal antibody (Product # PA5-82982) in Immunocytochemistry
Mon Dec 12 00:00:00 UTC 2022
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Science advances
Brown MS,Abdollahi B,Wilkins OM,Lu H,Chakraborty P,Ognjenovic NB,Muller KE,Jolly MK,Christensen BC,Hassanpour S,Pattabiraman DR
PA5-82982 was used in Immunocytochemistry, Immunohistochemistry (Paraffin), In Vitro Assay to develop an advanced multiplexed immunostaining approach using SUM149-derived orthotopic tumors and find that the EMT state and epithelial-mesenchymal heterogeneity are predictive of overall survival in a cohort of stage III breast cancer.
Fri Aug 05 00:00:00 UTC 2022
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Science advances
Brown MS,Abdollahi B,Wilkins OM,Lu H,Chakraborty P,Ognjenovic NB,Muller KE,Jolly MK,Christensen BC,Hassanpour S,Pattabiraman DR
PA5-82982 was used in Immunocytochemistry, Immunohistochemistry (Paraffin), In Vitro Assay to develop an advanced multiplexed immunostaining approach using SUM149-derived orthotopic tumors and find that the EMT state and epithelial-mesenchymal heterogeneity are predictive of overall survival in a cohort of stage III breast cancer.
Fri Aug 05 00:00:00 UTC 2022
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Science advances
Brown MS,Abdollahi B,Wilkins OM,Lu H,Chakraborty P,Ognjenovic NB,Muller KE,Jolly MK,Christensen BC,Hassanpour S,Pattabiraman DR
PA5-82982 was used in Immunocytochemistry, Immunohistochemistry (Paraffin), In Vitro Assay to develop an advanced multiplexed immunostaining approach using SUM149-derived orthotopic tumors and find that the EMT state and epithelial-mesenchymal heterogeneity are predictive of overall survival in a cohort of stage III breast cancer.
Fri Aug 05 00:00:00 UTC 2022
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Science advances
Brown MS,Abdollahi B,Wilkins OM,Lu H,Chakraborty P,Ognjenovic NB,Muller KE,Jolly MK,Christensen BC,Hassanpour S,Pattabiraman DR
PA5-82982 was used in Immunocytochemistry, Immunohistochemistry (Paraffin), In Vitro Assay to develop an advanced multiplexed immunostaining approach using SUM149-derived orthotopic tumors and find that the EMT state and epithelial-mesenchymal heterogeneity are predictive of overall survival in a cohort of stage III breast cancer.
Fri Aug 05 00:00:00 UTC 2022